GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Avalo Therapeutics AVTX · USD

Health Care · US listing · 🇺🇸 United States

Compare

7.27

+4.91%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Avalo Therapeutics

Our reporting

Next results

5 Nov 2026

Due on 5 Nov 2026. Analysts expect earnings of -0.59 a share.

Past results

Reported against what analysts expected

6 Aug 202613 May 202611 May 202623 Mar 20266 Nov 20257 Aug 2025
Earnings per share-0.83-0.98-1.25-0.74-2.19-1.92
Forecast-0.58-1.001.00-1.54-1.67-1.43
Revenue———$79,500——

Key events

  1. 29 Dec 2023240-to-1 reverse split
  2. 8 Jul 202212-to-1 reverse split
  3. 13 Nov 2015Listed

Avalo Therapeutics in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.